Medical News

RSS

Receptos raises $25 million through Series A financing

Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.

23 Nov 2009

Bio-Quant to be acquired by NexMed

NexMed, Inc., a developer of products based on the NexACT® technology, today announced that it has entered into a definitive agreement to acquire Bio-Quant, Inc., a revenue generating privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.

23 Nov 2009

Augusta woman sues Fairbank Farms over E. coli infected ground beef

As news broke that more Maine residents may be infected with E. coli from Fairbank Farms ground beef, an Augusta woman severely sickened in the E. coli outbreak has filed suit against the company. The lawsuit was filed in the Maine District Court by the plaintiff’s attorneys, Bill Marler of foodborne illness law firm Marler Clark, and Peter Felmley of the Portland firm Drummond, Woodsum, & MacMahon.

23 Nov 2009

AppDetectivePro solution from Application Security awarded Certificate of Networthiness by U.S. Army

Application Security, Inc., the leading provider of database security, risk and compliance solutions (SRC) for the enterprise, today announced that its has received a Certificate of Networthiness (CoN) from the U.S. Army Network Enterprise Technology Command (NETCOM) for its AppDetectivePro™ solution. With over one hundred thousand databases protected, AppDetectivePro is the defacto standard tool for database auditing.

23 Nov 2009

MMR Information Systems to add new feature in its personal health record website

MMR Information Systems, Inc. announced today it will add a clinical trials information service to its MyMedicalRecords Personal Health Record site, www.mymedicalrecords.com.

23 Nov 2009

Lannett CEO to participate in NYSE opening bell ringing ceremony

Lannett Company, Inc. (NYSE AMEX: LCI) today announced that President and Chief Executive Officer Arthur Bedrosian will ring the opening bell at the New York Stock Exchange at 9:30 a.m. Eastern on Monday, November 23, 2009.

23 Nov 2009

Phase 1 data of ARIAD Pharmaceuticals' pan-BCR-ABL inhibitor to be presented at the ASH meeting

ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD’s investigational, multi-targeted kinase inhibitor and pan-BCR-ABL inhibitor, AP24534, at the 51st Annual Meeting of the American Society of Hematology (ASH) being held in New Orleans, Louisiana, December 5-8, 2009.

23 Nov 2009

NAPRELAN Dose Card launched by Victory Pharma

Victory Pharma, Inc. ("Victory") announced today the launch of NAPRELAN® Dose Card, a further extension of Victory's NAPRELAN franchise.

23 Nov 2009

Holders of $121M outstanding Rural/Metro notes deliver the requisite consents

Rural/Metro Corporation, a leading provider of ambulance and private fire protection services, today announced that, pursuant to the terms of its previously announced tender offer and consent solicitation for its outstanding 9.875% Senior Subordinated Notes due 2015, holders of $121 million aggregate principal amount of the outstanding Notes (approximately 96.8%) have validly tendered their Notes and have validly delivered the requisite consents for the proposed amendments prior to the expiration of the consent date which was 5:00 pm, New York City time, on November 20, 2009.

23 Nov 2009

Nightingale Informatix announces financial results for the quarter and six months ended September 30, 2009

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the quarter and six months ended September 30, 2009. All results are reported in Canadian dollars unless otherwise stated.

23 Nov 2009

American Red Cross of Greater Cleveland to conduct Operation Save-A-Life Fire Safety Walk

In response to the recent deaths from multiple house fires in the City of Cleveland, The American Red Cross of Greater Cleveland in partnership with the City of Cleveland Fire Department, is conducting an Operation Save-A-Life Fire Safety Walk on the near west-side of Cleveland on Monday, November 23, 2009.

23 Nov 2009

Marriott UMUC's initiative to collect funds for Children’s Miracle Network

Armed with $5 bills, the shoppers lined up waiting for the doors to open. Sound like some kind of bizarre sale? This was no sale, it was the scene at the opening of the temporary thrift store at Marriott’s University of Maryland University College Inn and Conference Center. Local community members in need were invited to stuff as many clothes as they could into shopping bags for $5 a bag. All proceeds went to the Children’s Miracle Network (CMN).

23 Nov 2009

RXi Pharmaceuticals receives prestigious Innovation of the Year Award

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported that the Company has received Frost & Sullivan’s 2009 North American RNAi Therapeutic Design & Delivery Technology Innovation of the Year Award for the development of its proprietary RNAi compounds, rxRNA™, and advanced delivery approaches.

23 Nov 2009

New FluCide better than the older version

NanoViricides, Inc., announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide™ animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC (www.terrapinn.com/usaflu). These data clearly established that the new version of FluCide™ is superior to the older version.

23 Nov 2009

Most Canadians hope OAB symptoms will go away

A recent poll conducted by Leger Marketing, on behalf of the Powder Room - a national education program for those with overactive bladder (OAB) - asked 1,500 Canadians about their bladder health. The findings revealed that although people are experiencing OAB symptoms, most are choosing not to seek medical attention - perhaps assuming the frustrating and embarrassing symptoms will go away, or that they will just have to live with them.

23 Nov 2009

100th patient enrolled in Atrium Medical's iCAST Atrium Registry Ultrasound Study

Atrium Medical Corporation announced that the 100th patient was enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). The iCARUS study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease in the iliac artery.

23 Nov 2009

Kingston University receives £99,000 for cancer research

Scientists have begun a three-year study to analyse why cancer patients become resistant to treatments designed to fight the disease. A research team from Kingston University has been awarded £99,000 to investigate why some tumours are sensitive and respond to treatments and why other tumours do not.

23 Nov 2009

Verizon launches telehealth services

Time, distance and cost often hamper efforts to link patients with the right health care expert, causing further concern for those needing to consult with faraway doctors. Verizon is answering this need with new services for physicians, hospitals, clinics and insurers that enable providers to "see" patients through video consultations, as well as other collaboration services.

23 Nov 2009

Provectus Pharmaceuticals announces Phase 1 interim study data of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends to Phase 1 survival data.

23 Nov 2009

First Edition: November 23, 2009

Today's headlines indicate that even after Senate Majority Leader Harry Reid found victory Saturday night with the first health bill test vote, his measure is likely to be the subject of an even more intense debate as the measure moves forward.

23 Nov 2009